Colon Cancer Liver Metastasis Clinical Trial
Official title:
An Observational Study of TACE Hepatic Arterial Infusion of Oxaliplatin, Irinotecan and Raltitrexed Treatment for Refractory Liver Metastasis From Colorectal Cancer
The purpose of this study is to observe whether hepatic infusion by oxaliplatin, irinotecan and raltitrexed with or without embolization by lipiodol or microspheres are effective in the treatment of refratory liver metastasis from colorectal cancer.
Colorectal cancer is one of most popular cancer worldwide. Patients with liver metastasis have poor prognosis except for curative resection. Chemotherapy combined biologic agents have improved mCRC median progress free survival and median overall surivival, but it is difficult to deal with liver lesions after FOLFOX and FOLFIRI treatments failed. We aim to observe the safety and efficacy of hepatic infusion and embolization of oxaliplatin, irinotecan and raltitrexed treatment for refratory liver metastasis from colorectal cancer. ;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01540435 -
Perioperative Treatment of Resectable Liver Metastases
|
Phase 2 | |
| Terminated |
NCT01464593 -
Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
|
Phase 2 | |
| Completed |
NCT02090816 -
Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy
|
N/A | |
| Recruiting |
NCT04682665 -
Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases
|
||
| Completed |
NCT01730365 -
Optical Detection of Malignancy During Percutaneous Interventions
|
N/A | |
| Completed |
NCT01526200 -
Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases
|
N/A | |
| Terminated |
NCT03370198 -
Hepatic Transarterial Administrations of NKR-2 in Patients With Unresectable Liver Metastases From Colorectal Cancer
|
Phase 1 | |
| Completed |
NCT02781935 -
Diffusion-Weighted MRI for Liver Metastasis
|
||
| Completed |
NCT01891552 -
Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab
|
N/A | |
| Recruiting |
NCT05293041 -
Argipressin's Influence on Blood Loss During Hepatic Resection
|
Phase 4 | |
| Recruiting |
NCT03175016 -
Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer
|
Phase 2/Phase 3 | |
| Recruiting |
NCT02363049 -
Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer
|
Phase 3 | |
| Recruiting |
NCT02557490 -
Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases
|
Phase 4 | |
| Completed |
NCT03415126 -
A Study of ASN007 in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT04668872 -
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
|
||
| Completed |
NCT01522209 -
Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging
|
N/A | |
| Active, not recruiting |
NCT03310008 -
Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases
|
Phase 1 |